Market Cap

Catalent, Inc. Market Capitalization:

$10.27 Billion

USD as of July 1, 2024

business Catalent, Inc. Company Profile

Catalent, Inc. Main Stock Listing

NYSE: CTLT

Market Capitalization History of Catalent, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $80.13 B
MERCK Kommanditgesellschaft auf Aktien $71.24 B
Takeda Pharmaceutical Company Limited $41.23 B
Haleon plc $37.32 B
Teva Pharmaceutical Industries Limited $18.88 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Catalent, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2024 $7.85 B -5.63%
Jan. 1, 2023 $8.32 B -55.61%
Jan. 1, 2022 $18.74 B -9.67%
Jan. 1, 2021 $20.74 B 88.30%
Jan. 1, 2020 $11.01 B 65.45%
Jan. 1, 2019 $6.66 B -20.65%
Jan. 1, 2018 $8.39 B 73.92%
Jan. 1, 2017 $4.82 B 13.73%
Jan. 1, 2016 $4.24 B -14.81%
Jan. 1, 2015 $4.98 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Catalent, Inc. Categories

United States languages Healthcare languages Drug Manufacturers—Specialty & Generic
United States Healthcare United States Drug Manufacturers—Specialty & Generic

Stocks & Indices

Catalent, Inc. has the following listings and related stock indices.


Stock: NYSE: CTLT

Stock: FSX: 0C8

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.